Association study of the 5-HT2A receptor gene polymorphism, T102C and essential hypertension

被引:26
作者
Liolitsa, D [1 ]
Powell, JF [1 ]
Prince, M [1 ]
Lovestone, S [1 ]
机构
[1] Inst Psychiat, Dept Neurosci, London SE5 8AF, England
关键词
serotonin; essential hypertension; blood pressure; gender; association study;
D O I
10.1038/sj.jhh.1001177
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Serotonin dysfunction has been implicated in hypertension due to its ability to induce vasoconstriction via stimulation of 5-HT2 receptors and due to the antihypertensive effect of ketanserin, an antagonist at the 5-HT2A receptor subtype, expressed both on arteries and the brain, The silent T102C polymorphism in the 5-HT2A gene is in absolute linkage disequilibrium with a polymorphism in the promoter and may contribute to genetic predisposition possibly by modifying the transcription of the gene, Objective: To examine the genetic contribution of the T102C 5-HT2A polymorphism in essential hypertension in a case-control sample of UK residents. Design: The hypertensive group consisted of 342 subjects over 75 years and the community-based control group consisted of 319 subjects, Subjects were genotyped for the T102C polymorphism by Mspl restriction enzyme digestion following PCR amplification. Results: Sex-specific association analysis revealed significant differences between hypertensive and normotensive subjects in the genotypes distribution (P = 0.016) and allelic frequencies (P = 0.007) in the female group, The direction of significance was increased frequency of the 102-C allele in the hypertensive subjects, There were no association between haplotype and age or body mass index, which suggest that the effect of the T102C variant is not influenced by these variables, Conclusion: This data indicates that the T102C polymorphism in the 5-HT2A gene might be an independent risk factor for increased blood pressure in female individuals with essential hypertension.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 34 条
[11]   Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A [J].
Enoch, MA ;
Goldman, D ;
Barnett, R ;
Sher, L ;
Mazzanti, CM ;
Rosenthal, NE .
MOLECULAR PSYCHIATRY, 1999, 4 (01) :89-92
[12]   Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia [J].
Erdmann, J ;
ShimronAbarbanell, D ;
Rietschel, M ;
Albus, M ;
Maier, W ;
Korner, J ;
Bondy, B ;
Chen, K ;
Shih, JC ;
Knapp, M ;
Propping, P ;
Nothen, MM .
HUMAN GENETICS, 1996, 97 (05) :614-619
[13]  
Hoyer D, 1994, PHARMACOL REV, V46, P158
[14]   CHRONIC INHIBITION OF ENDOTHELIUM-DERIVED NITRIC-OXIDE SYNTHESIS CAUSES CORONARY MICROVASCULAR STRUCTURAL-CHANGES AND HYPERREACTIVITY TO SEROTONIN IN PIGS [J].
ITO, A ;
EGASHIRA, K ;
KADOKAMI, T ;
FUKUMOTO, Y ;
TAKAYANAGI, T ;
NAKAIKE, R ;
KUGA, T ;
SUEISHI, K ;
SHIMOKAWA, H ;
TAKESHITA, A .
CIRCULATION, 1995, 92 (09) :2636-2644
[15]   Lys173Arg and-344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension [J].
Komiya, I ;
Yamada, T ;
Takara, M ;
Asawa, T ;
Shimabukuro, M ;
Nishimori, T ;
Takasu, N .
HYPERTENSION, 2000, 35 (03) :699-703
[16]   AMPLIFYING INTERACTIONS BETWEEN SPASMOGENS IN VASCULAR SMOOTH-MUSCLE [J].
MACLENNAN, SJ ;
BOLOFO, ML ;
MARTIN, GR .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (04) :1145-1150
[17]   SEROTONIN (5HT) AND ITS ANTAGONISTS - INVOLVEMENT IN THE CARDIOVASCULAR-SYSTEM [J].
MARWOOD, JF ;
STOKES, GS .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1984, 11 (05) :439-455
[18]   VASCULAR RESPONSES TO 5-HYDROXYTRYPTAMINE IN GENETIC AND RENAL HYPERTENSIVE RATS [J].
MCGREGOR, DD ;
SMIRK, FH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1970, 219 (03) :687-&
[19]   Promoter polymorphism of the β2 bradykinin receptor gene is associated with essential hypertension [J].
Mukae, S ;
Aoki, S ;
Itoh, S ;
Nishio, K ;
Iwata, T ;
Ueda, H ;
Geshi, E ;
Fuzimaki, T ;
Katagiri, T .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1999, 63 (10) :759-762
[20]  
NACMIASB, 1999, NEUROSCI LETT, V277, P134